science

Technetium (99mTc) fanolesomab

Technetium (99mTc) fanolesomab is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Technetium (99mTc) fanolesomab rather than just read about it. In short: Technetium (99mTc) fanolesomab (trade name NeutroSpec, manufactured by Palatin Technologies) is a mouse monoclonal antibody formerly used to aid in the diagnosis of appendicitis. It is labeled with a radioisotope, technetium-99m (99mTc).

Key takeaways

Technetium (99mTc) fanolesomab belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Technetium (99mTc) fanolesomab to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Technetium (99mTc) fanolesomab from memory before moving on to harder problems.

Reference excerpt

Technetium (99mTc) fanolesomab (trade name NeutroSpec, manufactured by Palatin Technologies) is a mouse monoclonal antibody formerly used to aid in the diagnosis of appendicitis. It is labeled with a radioisotope, technetium-99m (99mTc).

History and use NeutroSpec was approved by the U.S. Food and Drug Administration (FDA) in June 2004 for imaging of patients with symptoms of appendicitis. It consisted of an intact murine (mouse) IgM monoclonal antibody against human CD15, labeled with technetium-99m so as to be visible on a gamma camera image. Since anti-CD15 antibodies bind selectively to white blood cells such as neutrophils, it could be used to localize the site of an infection.

Deaths and associated recall The FDA received reports from Palatin of 2 deaths and 15 life-threatening adverse events in patients who had received NeutroSpec.

These events occurred within minutes of administration of NeutroSpec and included shortness of breath, low blood pressure, and cardiopulmonary arrest. Affected patients required resuscitation with intravenous fluids, blood pressure support, and oxygen. Most, but not all, of the patients who experienced these events had existing cardiac and/or pulmonary conditions that may have placed them at higher risk for these adverse events. A review of all post-marketing reports showed an additional 46 patients who experienced adverse events that were similar but less severe. All of the reactions occurred immediately after NeutroSpec was administered.

Marketing of the product was suspended in December 2005.

References

Worked examples

Example 1 — a first encounter with Technetium (99mTc) fanolesomab

Start with the simplest possible case. Write down what Technetium (99mTc) fanolesomab claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Technetium (99mTc) fanolesomab before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Technetium (99mTc) fanolesomab ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Technetium (99mTc) fanolesomab

In research: Technetium (99mTc) fanolesomab appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Technetium (99mTc) fanolesomab in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Technetium (99mTc) fanolesomab is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antibody-technetium-99m conjugates, Drugs not assigned an ATC code, Monoclonal antibodies, so understanding it makes those chapters shorter.
In everyday life: Look for Technetium (99mTc) fanolesomab outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Technetium (99mTc) fanolesomab” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Technetium (99mTc) fanolesomab in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Technetium (99mTc) fanolesomab means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Technetium (99mTc) fanolesomab out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Technetium (99mTc) fanolesomab in simple terms?

Why does Technetium (99mTc) fanolesomab matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Technetium (99mTc) fanolesomab?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Technetium (99mTc) fanolesomab.